# FDA recall D-0036-2020

> **Shire Human Genetic Therapies, Inc.** · Class I · drug recall initiated 2019-09-12.

## Product

Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0203-02

## Reason for recall

Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing

## Distribution

Product was distributed throughout the United States.

## Key facts

- **Recall number:** D-0036-2020
- **Recalling firm:** Shire Human Genetic Therapies, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-12
- **Report date:** 2019-10-02
- **Termination date:** 2021-03-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lexington, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0036-2020

## Citation

> AI Analytics. FDA recall D-0036-2020. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/D-0036-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*